Trial intelligence / Profile preview

Tetrabenazine adjunctive to risperidone in first-episode schizophrenia

2009-011594-33Phase 3Active

Sponsor
LWL University Hospital Bochum
Start
Oct 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in schizophrenia comparing Tetrabenazine + risperidone with Placebo + risperidone (2 arms). Primary endpoint: Change in Positive and Negative Syndrome Scale. Started Oct 2009; status: active.

02

Drugs

tetrabenazinerisperidone
03

Conditions

schizophrenia

Beyond the preview

Go deeper on 2009-011594-33.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-011594-33.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call